Alan L. Crane, Director at MOMENTA PHARMACEUTICALS INC (MNTA), sold 61,200 shares at $16.41 ($1000K) on 2006-11-16, disclosed to the SEC on 2006-11-20.
Scheduled sale ($1000k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.30 | 2,900 | $47K | 4.7% |
| 2 | $16.31 | 1,500 | $24K | 2.4% |
| 3 | $16.32 | 2,820 | $46K | 4.6% |
| 4 | $16.33 | 44,045 | $719K | 71.9% |
| 5 | $16.34 | 2,380 | $39K | 3.9% |
| 6 | $16.35 | 6,000 |
| $98K |
| 9.8% |
| 7 | $16.40 | 100 | $2K | 0.2% |
| 8 | $16.41 | 100 | $2K | 0.2% |
| 9 | $16.43 | 100 | $2K | 0.2% |
| 10 | $16.55 | 1,255 | $21K | 2.1% |
| Total | $16.33 avg | 61,200 | $1000K | 100% |
| Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |
| MNTA | SELL | 2007-01-12 | $873K | — | Filing → |
| MNTA | SELL | 2006-12-20 | $1.0M | — | Filing → |